AtriCure Firm Plans to Go Public on Nasdaq

AtriCure, a high-tech medical device company based in West Chester, Ohio, plans to go public with an initial offering of stock later this year. The company said that it has entered into an agreement with UBS Investment Bank and Piper Jaffrey to manage the offering of an as-yet-undetermined number of shares that would trade under the ATRC symbol on the Nasdaq exchange. Company officials hope to raise $57.5 million through the initial public offering.

The Cincinnati Post (http://news.cincypost.com/apps/pbcs.dll/article?AID=/20050422/BIZ/504220332/1001)